HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emmanuel Bourdon Selected Research

fermented papaya preparation

4/2016Fermented papaya preparation modulates the progression of N-methyl-N-nitrosourea induced hepatocellular carcinoma in Balb/c mice.
10/2014Diabetes as a risk factor to cancer: functional role of fermented papaya preparation as phytonutraceutical adjunct in the treatment of diabetes and cancer.
3/2014Relationship between fermented papaya preparation supplementation, erythrocyte integrity and antioxidant status in pre-diabetics.
11/2013The inhibitory effect of a fermented papaya preparation on growth, hydrophobicity, and acid production of Streptococcus mutans, Streptococcus mitis, and Lactobacillus acidophilus: its implications in oral health improvement of diabetics.
5/2012Effects of a short term supplementation of a fermented papaya preparation on biomarkers of diabetes mellitus in a randomized Mauritian population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emmanuel Bourdon Research Topics

Disease

7Type 2 Diabetes Mellitus (MODY)
01/2018 - 10/2006
6Inflammation (Inflammations)
06/2017 - 05/2005
5Hemolysis
01/2020 - 01/2005
4Hyperglycemia
01/2017 - 01/2012
3Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 10/2014
3Obesity
07/2017 - 12/2009
3Hepatocellular Carcinoma (Hepatoma)
06/2017 - 09/2014
3Diabetes Mellitus
06/2014 - 05/2012
2Atherosclerosis
05/2021 - 09/2006
2Neoplasms (Cancer)
10/2020 - 10/2014
2Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2017 - 01/2013
2Insulin Resistance
07/2017 - 01/2013
2Ischemia
01/2017 - 01/2012
2Infections
12/2014 - 11/2013
2Fibrosis (Cirrhosis)
10/2014 - 05/2005
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2012 - 01/2002
1Diabetes Complications
05/2020
1Necrosis
06/2017
1Infarction (Infarctions)
01/2017
1Herpes Zoster
01/2017
1Vascular Diseases (Vascular Disease)
01/2017
1Wounds and Injuries (Trauma)
12/2014
1Prostatic Neoplasms (Prostate Cancer)
10/2014
1Hemorrhage
10/2014
1Carcinoma (Carcinomatosis)
09/2014
1Metabolic Diseases (Metabolic Disease)
06/2014
1Periodontitis
11/2013
1Dental Caries (Decay, Dental)
11/2013
1Gingivitis
11/2013
1Liposarcoma
12/2009
1Pathologic Processes
06/2008
1Down Syndrome (Down's Syndrome)
07/2005

Drug/Important Bio-Agent (IBA)

11AntioxidantsIBA
10/2020 - 01/2005
8AlbuminsIBA
01/2017 - 10/2006
7Advanced Glycation End ProductsIBA
05/2020 - 12/2009
7Free RadicalsIBA
10/2014 - 01/2005
5fermented papaya preparationIBA
04/2016 - 05/2012
4Proteins (Proteins, Gene)FDA Link
03/2014 - 01/2002
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 06/2017
3Biological ProductsIBA
07/2017 - 10/2014
3CytokinesIBA
06/2017 - 05/2005
3Glucose (Dextrose)FDA LinkGeneric
01/2017 - 01/2012
2LipidsIBA
05/2021 - 10/2014
2Interleukin-6 (Interleukin 6)IBA
06/2017 - 01/2017
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
06/2017 - 01/2002
2Cardiotonic Agents (Cardiac Stimulants)IBA
01/2017 - 01/2012
2Biomarkers (Surrogate Marker)IBA
01/2017 - 05/2012
2CopperIBA
06/2014 - 01/2005
2MetalsIBA
06/2014 - 01/2005
2LDL Lipoproteins (beta Lipoproteins)IBA
09/2006 - 01/2005
1diphenyl (biphenyl)IBA
10/2020
1BromidesIBA
10/2020
1LiraglutideFDA Link
01/2018
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2018
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
06/2017
1Sulfhydryl Compounds (Thiols)IBA
01/2017
1Bovine Serum AlbuminIBA
01/2017
1FructosamineIBA
01/2017
1Interleukin-8 (Interleukin 8)IBA
01/2017
1ischemia-modified albuminIBA
01/2017
1ClaudinsIBA
01/2017
1EnzymesIBA
04/2016
1Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
04/2016
1Serum AlbuminIBA
03/2015
1Nonesterified Fatty Acids (NEFA)IBA
03/2015
1Fatty Acids (Saturated Fatty Acids)IBA
03/2015
1lysophosphatidic acidIBA
12/2014
1LipopolysaccharidesIBA
12/2014
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
12/2014
1Phospholipase DIBA
12/2014
1DNA (Deoxyribonucleic Acid)IBA
10/2014
1Cell-Free Nucleic AcidsIBA
10/2014
1Insulin (Novolin)FDA Link
10/2014
1Hemoglobins (Hemoglobin)IBA
10/2014
1IonsIBA
06/2014
1ZincIBA
06/2014
1Complement System Proteins (Complement)IBA
11/2013
1LDL CholesterolIBA
01/2013
1TeaIBA
01/2013
1Triglycerides (Triacylglycerol)IBA
01/2013
1Oxygen (Dioxygen)IBA
01/2012
1Krebs-Henseleit solutionIBA
01/2012
1Streptozocin (Streptozotocin)FDA Link
01/2012
1Oleanolic AcidIBA
01/2012
1QuercetinIBA
12/2009
1alpha-TocopherolFDA Link
12/2009
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
12/2009
12,2'-azobis(2-amidinopropane) (ABAP)IBA
12/2009
1caffeic acidIBA
12/2009
1oxidized low density lipoproteinIBA
09/2006
1Proteasome Endopeptidase Complex (Proteasome)IBA
07/2005
1Transforming Growth Factor beta1 (TGF beta 1)IBA
05/2005
1alpha 1 Chain Collagen Type IIBA
05/2005
1Cystathionine beta-Synthase (Serine Sulfhydrase)IBA
05/2005
1Tissue Inhibitor of Metalloproteinase-1IBA
05/2005

Therapy/Procedure

2Therapeutics
10/2020 - 10/2014
1Glycemic Control
10/2014
1Oral Hygiene (Dental Hygiene)
11/2013
1Ligation
01/2012
1Phytotherapy (Herbal Therapy)
12/2009